401 Series A healthtech investors

Top 5 Series A healthtech investors, ranked by recent fund activity

Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series A is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.

1. Motley Fool Ventures

   Type: VC firm · HQ: Alexandria, VA · Stages: Series A · Focus: Healthtech, Fintech, AI, Proptech · Latest activity: Portfolio news, Oct 2026 · Fund size on file: $300M (SEC Form D, 2022)

   Portfolio news dated Oct 2026; $300M fund on file (SEC Form D, 2022); states healthtech and digital health as a focus; backs Series A; 8 named decision-makers on file.

2. IW Capital

   Type: SEIS/EIS fund · HQ: London, United Kingdom · Stages: Series A · Focus: Healthtech, AI, SaaS, Fintech · Latest activity: New deal, Oct 2026 · Fund size or assets: £185M (own site)

   Dated new deal in Oct 2026; £185M on file (own site); states healthtech and digital health as a focus; backs Series A; 8 named decision-makers on file.

3. Felicis

   Type: VC firm · HQ: Menlo Park, CA · Stages: Seed, Series A · Focus: Healthtech, AI, Developer Tools, Cybersecurity · Latest activity: New deal, Oct 2026 · Fund size on file: $900M (SEC Form D, 2025)

   Dated new deal in Oct 2026; $900M fund on file (SEC Form D, 2025); states healthtech and digital health as a focus; backs seed, Series A; 8 named decision-makers on file.

4. Innovation Industries

   Type: VC firm · HQ: Amsterdam, Netherlands · Stages: Series A, Series B, Growth · Focus: Healthtech, Deep Tech, AI, Food and Beverage · Latest activity: New fund, Oct 2026 · Fund size or assets: €1.0B (own site)

   Latest fund filing dated Oct 2026; €1.0B on file (own site); states healthtech and digital health as a focus; backs Series A, Series B, growth-stage; 4 named decision-makers on file.

5. Gresham House Ventures

   Type: VC firm · HQ: London, United Kingdom · Stages: Series A, Growth · Focus: Healthtech, AI, Marketing Tech, Fintech · Latest activity: New deal, Sep 2026 · Fund size or assets: £200M (own site)

   Dated new deal in Sep 2026; £200M on file (own site); states healthtech and digital health as a focus; backs Series A, growth-stage; 8 named decision-makers on file.

First 25 of 401 Series A healthtech investors

You are seeing 25 of 401. The full list adds 376 more investors and 1,963 named decision-makers.

Need fewer rows than the whole file? The investor matching tool, opened here for healthtech and digital health and Series A, builds a shortlist of up to 300 matching investors for $49, one-time.

How these 401 break down

Questions

Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to healthtech and digital health and Series A. Guide: how to find investors for a healthtech and digital health startup. Markdown version of this page.